Zalicus Inc. (NASDAQ:ZLCS) continues to surge in the market by highs of 65.05% after announcing a merger agreement with Boston Based, Epirus biopharmaceutical, in an all-stock transaction. Epirus specializes in the development and commercialization of monoclonal antibodies. Following closure of the transaction, Zalicus will be renamed Epirus Biopharmaceutical Inc. Zalicus Inc (NASDAQ:ZLCS) shares after opening at $1.22 moved to $1.74 on last trade day and at the end of the day closed at $1.35. Company price to sales ratio in past twelve months was calculated as 11.42 and price to cash ratio as 6.62. Zalicus Inc (NASDAQ:ZLCS) showed a positive weekly performance of 11.57%.
Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Apr. 1 announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio’s Chief Operating Officer Dr. Niranjan Sardesai. Prior to joining Inovio, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into successful commercial entities; he supported the growth of several pharmaceutical companies in the quality and compliance areas. Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares advanced 2.67% in last trading session and ended the day on $2.69. INO return on equity ratio is recorded as -144.40% and its return on assets is -92.70%. Inovio Pharmaceuticals Inc (NYSEMKT:INO) yearly performance is 368.42%.
Wave Systems Corp. (NASDAQ:WAVX) offers simple, cost-effective solutions that protect the user at the hardware level, eliminating or reducing the need for software layers. Wave Systems’ cloud-based solutions will primarily help Micron to improve its offerings in segments such as fraud protection, advanced persistent threat (APT) protection, zero-day vulnerabilities, endpoint security as well as threat intelligence services. Wave Systems Corp. (NASDAQ:WAVX) shares moved down -4.29% in last trading session and was closed at $1.34, while trading in range of $ 1.30 – 1.64. Wave Systems Corp. (NASDAQ:WAVX) year to date (YTD) performance is 47.25%.
Galena Biopharma Inc (NASDAQ:GALE) is subject of the U.S. Securities Exchange Commission investigations. The biotech is facing claims of authorizing unlawful marketing campaigns that created a buzz in the stock and inflated shares, allowing insiders to make millions of dollars through the sale of thousands of shares. Galena Biopharma Inc (NASDAQ:GALE) weekly performance is -20.17%. On last trading day company shares ended up $1.86. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -43.54%. Analysts mean target price for the company is $6.67.
Leave a Reply